Results 171 to 180 of about 283,019 (191)

Drug repurposing: progress, challenges and recommendations

Nature Reviews Drug Discovery, 2018
Sudeep P Pushpakom, Francesco Iorio, Patrick A Eyers   +2 more
exaly  

[Drug resistance in malignant neoplasms].

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1982
openaire   +1 more source

[Advances in the study of reversal of multidrug resistance in neoplasm with Chinese herbal drugs].

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2002
Z, Liu, Z, Xu, N, Shou
openaire   +1 more source

Polymer–drug conjugate therapeutics: advances, insights and prospects

Nature Reviews Drug Discovery, 2018
Iriny Ekladious, Yolonda L Colson, Mark Grinstaff   +2 more
exaly  

A comprehensive map of molecular drug targets

Nature Reviews Drug Discovery, 2016
Rita Santos, Oleg Ursu, Anna Gaulton
exaly  

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery, 2017
Fabien Vincent, Jonathan A Lee, Marco Prunotto   +2 more
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Subcellular targeting strategies for drug design and delivery

Nature Reviews Drug Discovery, 2010
Lawrence Rajendran, Hans-Joachim Knölker   +1 more
exaly  

Studies on drug resistance. I. Distribution of l-beta-D-arabinofuranosylcytosine, cytidine and deoxycytidine in mice bearing ara-C-sensitive and-resistant P815 neoplasms.

Biochemical pharmacology, 1969
K, Uchida, W, Kreis
openaire   +1 more source

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
exaly